Why the study?
Although early outcomes and low perioperative complications were established in the S-ICD PAS cohort, data detailing spontaneous arrhythmias and clinical outcomes were lacking.
Population
1,637 de novo patients from 86 U.S. centers
Design
Prospective registry
Follow-up
365 days
Authors
Loading...
Low peri-operative complications in representative S-ICD patients support safety; leaves open long-term arrhythmia outcomes versus transvenous ICDs.
The S-ICD demonstrated a high complication-free rate and excellent shock efficacy for ventricular arrhythmias at 1 year in a predominantly primary prevention U.S. cohort.
Burke et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: